You have 9 free searches left this month | for more free features.

Condition

Advanced Solid Tumors Which Are cMET-dependent (1)

Non Small Cell Lung Cancer (1)

Overall Status

Recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Novartis Pharmaceuticals (2)

Collaborator

Intervention

capmatinib (2)

nazartinib (2)

gefitinib (1)

osimertinib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

nazartinib

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Non Small Cell Lung Cancer Trial in Worldwide (Capmatinib, Nazartinib)

Terminated

Non Small Cell Lung Cancer

Capmatinib
Nazartinib

Boston, Massachusetts
+18 more

Jul 20, 2022

Advanced Solid Tumors Which Are cMET-dependent Trial in Worldwide (Capmatinib, Nazartinib, Gefitinib)

Recruiting

Advanced Solid Tumors Which Are cMET-dependent

Capmatinib
+3 more

Boston, Massachusetts
+12 more

Jan 27, 2023